Latest Articles

Publication Date
Hormonal Environment Shapes the Oral Microbiome.

Hormones are present in oral fluids and undergo dynamic changes throughout life. Hormonal changes can influence the interactions between the microbial community and the host. The oral microbiome is sensitive …

Published: March 21, 2025, midnight
Real-World Data Support Dostarlimab Combo Benefit in RUBY Trial - Cancer Network

Real-World Data Support Dostarlimab Combo Benefit in RUBY Trial Cancer Network

Published: March 20, 2025, 8:01 p.m.
Nearly 100% of cancer identified by new AI, easily outperforming doctors - New Atlas

Nearly 100% of cancer identified by new AI, easily outperforming doctors New Atlas

Published: March 20, 2025, 9:32 a.m.
Glypican3 and serglycin as potential biomarkers involved in the pathogenesis of ovarian endometriosis.

Endometriosis, a non-malignant gynecological disorder characterized by debilitating symptoms, displays several cancer-like characteristics, including metastatic behavior and extracellular matrix (ECM) remodeling. The dynamics of ECM are largely influenced by proteoglycans …

Published: March 20, 2025, midnight
AI model detects endometrial cancer at almost 100 per cent accuracy - NT News

AI model detects endometrial cancer at almost 100 per cent accuracy NT News

Published: March 19, 2025, 3:45 p.m.
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı

Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı

Published: March 19, 2025, 2:55 p.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - MSN

Investigational ADC Shows Promise in Advanced Endometrial Cancer MSN

Published: March 19, 2025, 1:18 a.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - Medpage Today

Investigational ADC Shows Promise in Advanced Endometrial Cancer Medpage Today

Published: March 18, 2025, 8:07 p.m.
The Importance of Spotting Endometrial Cancer - Curetoday.com

The Importance of Spotting Endometrial Cancer Curetoday.com

Published: March 18, 2025, 3:24 p.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology

Published: March 18, 2025, 10:24 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!